Position in ARGX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$78,279,148
+$32,950,262 QoQ
Shares Held
107,195
+98.9% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. ARGX ranks #13 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in ARGX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,279,148 | 107,195 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $45,328,886 | 53,902 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $47,930,336 | 64,985 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $32,395,199 | 58,770 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $36,340,511 | 61,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $46,376,535 | 75,409 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $44,497,178 | 82,086 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $40,241,423 | 93,576 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $41,231,933 | 104,724 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $30,349,564 | 79,777 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $40,816,597 | 83,023 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $5,170,271 | 13,648 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||